logo
USA Rare Earth Reports its First Quarter 2025 Financial Results

USA Rare Earth Reports its First Quarter 2025 Financial Results

Yahoo14-05-2025

STILLWATER, Okla., May 14, 2025 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) ('USAR' or the 'Company') today announced its financial results for the first quarter ended March 31, 2025.
First Quarter Highlights
Merged with Inflection Point and began trading on Nasdaq on March 14
Commissioned our Innovations Lab at our Stillwater, Oklahoma magnet facility, a critical milestone for the company which officially launched our sales and qualification work with potential customers
Hired multiple key employees in engineering, production, finance, and operations
Signed our first customer MOU for rare earth sintered magnet production in 2026
Produced dysprosium oxide from the Round Top deposit with a purity of over 99%
'USA Rare Earth is ramping up quickly in 2025 to begin delivering finished magnets to our customers,' said Joshua Ballard, CEO. 'We have raised over $100 million since the start of the year in support of the business. In Stillwater, Oklahoma, we opened our Innovations Lab, started prototyping magnets, and are moving quickly to commission the first line of our 310,000-square-foot magnet facility. We are also meaningfully advancing our processing technologies in Colorado to unlock the value we hold at Round Top Mountain in Texas.'
Mr. Ballard added: 'We are experiencing a 'Manhattan Project' moment in America. As a country, we must invest in and rebuild our rare earth supply chain as unprecedented geopolitics have highlighted the structural need to protect our domestic defense, industrial and technology industries. We are seeing robust interest from domestic manufacturers eager to use magnets that are made here in the USA. Our growth in 2026 will reflect this growing demand. Our mission has prepared us for this moment, and we are determined to deliver for the American people.'
Forward-looking Statements Certain matters discussed in this press release and on the conference call (see information below) are or contain 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. These statements include statements relating to the Company's expectations for future development, operations, business strategies and financial performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. Words such as 'anticipate', 'believe', 'can', 'continue', 'could', 'estimate', 'expect', 'forecast', 'intend', 'may', 'might', 'plan', 'possible', 'potential', 'predict', 'project', 'seek', 'should', 'strive', 'target', 'will', 'would' and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.
Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from our expectations. These risks and uncertainties include, but are not limited to: risks related to the development of our magnet production facility and the timing of expected production milestones; competition in the magnet manufacturing industry; our ability to grow and manage growth profitably; our ability to build or maintain relationships with customers and suppliers; our ability to retain management and key employees; the supply and demand for rare earth minerals; the timing and amount of future production; costs of production, capital expenditures and requirements for additional capital, including the need to raise additional capital to implement our strategic plan; the substantial doubt regarding our ability to continue as a going concern for the twelve months following the issuance of our first quarter 2025 condensed consolidated financial statements; the timing of future cash flow provided by operating activities, if any; uncertainty in any mineral estimates, uncertainty in any geological, metallurgical, and geotechnical studies and opinions; and transportation risks. Detailed information regarding factors that may cause actual results to differ materially has been and will be included in the Company's periodic filings with the SEC, including the Company's Form 10-K that the Company filed with the SEC on March 31, 2025 and the Company's latest Quarterly Report on Form 10-Q. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors. Any forward-looking statements speak only as of their date, and we undertake no obligation to update any forward-looking statements to reflect events or circumstances occurring after their date or to reflect the occurrence of unanticipated events.
Use of Non-GAAP Financial Measures This press release includes certain non-GAAP financial measures, including adjusted net loss attributable to common shareholders (defined as 'adjusted net loss'), adjusted undistributed net loss to common shareholders (defined as 'adjusted undistributed net loss'), and adjusted undistributed net loss per common share (defined as 'adjusted net loss per common share'). Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position, or cash flows that either exclude or include amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with generally accepted accounting principles in the United States of America, or GAAP. These non-GAAP financial measures do not reflect a comprehensive system of accounting, differ from GAAP measures with the same captions, and may differ from non-GAAP financial measures with the same or similar captions that are used by other companies. As such, these non-GAAP measures should be considered as a supplement to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP.
We believe these non-GAAP measures of financial results provide useful supplemental information to management and investors regarding certain financial and business trends related to our financial condition and results of operations, and as a supplemental tool for investors to use in evaluating our ongoing operating results and trends and in comparing our financial measures with other companies that present similar non-GAAP financial measures. We use these non-GAAP financial measures to analyze our operating performance and future prospects, develop internal budgets and financial goals, and to facilitate period-to-period comparisons. We believe these non-GAAP financial measures reflect an additional way of viewing aspects of its operations that, when viewed with our GAAP results, provide a more complete understanding of factors and trends affecting its business. Current and prospective
investors should review our audited annual and unaudited interim financial statements, which are filed with the U.S. Securities and Exchange Commission, and not rely on any single financial measure to evaluate our business.
Notes to the Financial Results
Adjusted net loss is a non-GAAP financial measure that the Company defines as net income (loss) attributable to common shareholders which excludes gain on fair market value of financial instruments.
Adjusted undistributed net loss is a non-GAAP financial measure that the Company defines as net income (loss) attributed to common shareholders which excludes gain on fair market value of financial instruments, declared and undeclared dividends, and accretions.
Adjusted net loss per common share is a non-GAAP financial measure that the Company defines as net income (loss) attributed to common shareholders which excludes gain on fair market value of financial instruments, declared and undeclared dividends, and accretions, divided by basic shares outstanding.
Conference Call to Discuss Financial Results The Company will hold a conference call on Wednesday, May 14, 2025, 4:00 PM CT / 5:00 PM ET to discuss its first quarter 2025 results. Please see below for dial-in information.
LIVE CONFERENCE Q&A CALL: Wednesday, May 14, 2025, 4:00 PM CT / 5:00 PM ET US / Canada Toll-Free: +1 (866) 652-5200 Local / International Toll: +1 (412) 317-6060
CONFERENCE Q&A CALL REPLAY: Available approximately three hours after conclusion of the live call. Expiration: June 14, 2025 US Toll-Free: +1 (877) 344-7529 Canada Toll-Free: +1 (877) 344-7529 Local / International Toll: +1 (412) 317-0088 Access code: 2627439
Investors may also access the live call and the replay over the internet on the 'Events' page of the Company's website located at https://event.choruscall.com/mediaframe/webcast.html?webcastid=Cvh2W0BA.
Disclosure Information USA Rare Earth uses the investor relations section on its website as means of complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor USA Rare Earth's investor relations website in addition to following USA Rare Earth's press releases, SEC filings, and public conference calls and webcasts.
About USA Rare Earth USA Rare Earth (Nasdaq: USAR) is developing a NdFeB magnet manufacturing plant in Stillwater, Oklahoma, and intends to establish domestic rare earth and critical minerals supply, extraction, and processing capabilities to both supply its magnet manufacturing plant and market surplus materials to third parties. Rare earth magnets are critical to various business sectors and industries, including the defense, automotive, aviation, industrial, AI Robotics, medical, and consumer electronics industries, among others. USAR is planning to take a broad approach to the industries it serves with the intention of providing high quality NdFeB magnets to a variety of industries and customers. USAR's focus on developing domestic rare earth production aligns with national priorities, offering the potential of a sustainable and secure domestic supply of materials critical to key industries.
Contact Investor Relations ir@USARE.com
USA Rare Earth, Inc. Condensed Consolidated Balance Sheets (in thousands)
As of
March 31,
December 31,
2025
2024
(unaudited)
ASSETS
Current assets:
Cash and cash equivalents
$
23,351
$
16,761
Deferred offering costs
-
5,134
Prepaid expenses and other current assets
2,428
378
Total current assets
25,779
22,273
Non-current assets:
Property, plant and equipment, net
30,122
26,529
Mineral interests, at cost
17,125
17,125
Equipment deposits
3,572
3,060
Other non-current assets
477
82
Total non-current assets
51,296
46,796
Total assets
$
77,075
$
69,069
LIABILITIES, MEZZANINE AND STOCKHOLDERS' (DEFICIT) EQUITY
Liabilities
Accounts payable
$
3,113
$
1,823
Accrued liabilities
3,831
3,071
Deferred grants
8,200
8,200
Earnout liability
46,232
-
Warrant liability
34,475
-
Finance and operating lease liabilities
1,470
23
Other liabilities
13
2,008
Total liabilities
97,334
15,125
Mezzanine equity
32,397
19,923
Stockholders' (deficit) equity
(52,656
)
34,021
Total liabilities, mezzanine and stockholders' (deficit) equity
$
77,075
$
69,069
USA Rare Earth, Inc. Condensed Consolidated Statements of Operations (in thousands, except per share data) (Unaudited)
For the Three Months Ended March 31,
2025
2024
Operating costs and expenses
Selling, general and administrative
$
7,029
$
2,647
Research and development
1,689
2,051
Total operating costs and expenses
8,718
4,698
Operating loss
(8,718
)
(4,698
)
Other income
Gain on fair market value of financial instruments
60,300
1
Interest, net, dividend income and other expense
100
25
Total other income
60,400
26
Net income (loss)
51,682
(4,672
)
Net loss attributable to non-controlling interest
(150
)
(200
)
Net income (loss) attributable to common stockholders
$
51,832
$
(4,472
)
Net income (loss) per common share - basic
$
0.75
$
(0.11
)
Net income (loss) per common share - diluted
$
0.58
$
(0.11
)
USA Rare Earth, Inc. Condensed Consolidated Statements of Cash Flows (in thousands) (Unaudited)
For the Three Months Ended March 31,
2025
2024
Cash Flows From Operating Activities:
Net income (loss)
$
51,682
$
(4,672
)
Adjustments to reconcile net income (loss) to net cash (used in) provided from operating activities
(58,869
)
599
Changes in assets and liabilities
(3,142
)
(160
)
Net cash used in operating activities
(10,329
)
(4,233
)
Cash Flows From Investing Activities:
Purchase of property, plant and equipment
(2,011
)
(39
)
Equipment deposits
(1,039
)
(980
)
Cash used in investing activities
(3,050
)
(1,019
)
Cash Flows From Financing Activities:
Proceeds from issuance of preferred stock and warrants
23,250
-
IPXX contribution of capital through merger
22,867
-
Prepayment of forward purchase agreements
(20,789
)
-
Proceeds from early termination of forward purchase agreements
3,322
-
Issuance costs
(8,681
)
(405
)
Net cash provided by (used in) financing activities
19,969
(405
)
Net increase (decrease) in cash
6,590
(5,657
)
Cash and cash equivalents, beginning of year
16,761
13,199
Cash and cash equivalents, end of period
$
23,351
$
7,542
USA Rare Earth, Inc. Reconciliation of Non-GAAP Financial Measures(1) (in thousands) (Unaudited)
This press release includes certain non-GAAP financial information because we plan and manage our business using such information. The following table reconciles the GAAP financial information to the non-GAAP financial information.
For the Three Months Ended March 31,
2025
2024
Net income (loss) attributable to common stockholders
$
51,832
$
(4,472
)
Gain on fair market value of financial instruments
(60,300
)
(1
)
Adjusted net loss(2)
(8,468
)
(4,473
)
Declared and undeclared dividends, and accretions
(3,562
)
(1,792
)
Adjusted undistributed net loss(2)
$
(12,030
)
$
(6,265
)
Adjusted net loss per common share - basic and diluted(2)
$
(0.19
)
$
(0.11
)
Amounts may not total due to rounding.
Refer to the section 'Use of Non-GAAP Financial Measures' for description of items included in adjustments.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Those who invested in BrightSpire Capital (NYSE:BRSP) three years ago are up 2.0%
Those who invested in BrightSpire Capital (NYSE:BRSP) three years ago are up 2.0%

Yahoo

time23 minutes ago

  • Yahoo

Those who invested in BrightSpire Capital (NYSE:BRSP) three years ago are up 2.0%

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But the risk of stock picking is that you will likely buy under-performing companies. Unfortunately, that's been the case for longer term BrightSpire Capital, Inc. (NYSE:BRSP) shareholders, since the share price is down 29% in the last three years, falling well short of the market return of around 64%. Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. BrightSpire Capital wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Shareholders of unprofitable companies usually desire strong revenue growth. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size. In the last three years, BrightSpire Capital saw its revenue grow by 0.5% per year, compound. Given it's losing money in pursuit of growth, we are not really impressed with that. Indeed, the stock dropped 9% over the last three years. If revenue growth accelerates, we might see the share price bounce. But ultimately the key will be whether the company can become profitability. You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values). Take a more thorough look at BrightSpire Capital's financial health with this free report on its balance sheet. It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. In the case of BrightSpire Capital, it has a TSR of 2.0% for the last 3 years. That exceeds its share price return that we previously mentioned. And there's no prize for guessing that the dividend payments largely explain the divergence! BrightSpire Capital shareholders are up 1.5% for the year (even including dividends). Unfortunately this falls short of the market return. It's probably a good sign that the company has an even better long term track record, having provided shareholders with an annual TSR of 5% over five years. It may well be that this is a business worth popping on the watching, given the continuing positive reception, over time, from the market. It's always interesting to track share price performance over the longer term. But to understand BrightSpire Capital better, we need to consider many other factors. Case in point: We've spotted 1 warning sign for BrightSpire Capital you should be aware of. Of course BrightSpire Capital may not be the best stock to buy. So you may wish to see this free collection of growth stocks. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio

Oil Tanker Titans Stay Calm But Cautious After Mideast Warnings
Oil Tanker Titans Stay Calm But Cautious After Mideast Warnings

Bloomberg

time24 minutes ago

  • Bloomberg

Oil Tanker Titans Stay Calm But Cautious After Mideast Warnings

Several of the world's largest ocean-tanker operators said they remained calm but cautious after risk warnings from naval forces for vessels operating in and around the Persian Gulf, the world's largest oil-producing region. The risk notices were issued around the same time as US ordered some staff to leave its embassy in Baghdad on Wednesday, and followed threats by Tehran to strike American assets in the region in the event Iran is attacked over its nuclear program.

Biological Wastewater Treatment Market Report 2025, with Profiles of Notable Players Veolia, SUEZ, Ecolab, Xylem, Pentair, AECOM, Aquatech, Evoqua Water Technologies, Organica Water & more
Biological Wastewater Treatment Market Report 2025, with Profiles of Notable Players Veolia, SUEZ, Ecolab, Xylem, Pentair, AECOM, Aquatech, Evoqua Water Technologies, Organica Water & more

Yahoo

time25 minutes ago

  • Yahoo

Biological Wastewater Treatment Market Report 2025, with Profiles of Notable Players Veolia, SUEZ, Ecolab, Xylem, Pentair, AECOM, Aquatech, Evoqua Water Technologies, Organica Water & more

The Biological Wastewater Treatment Market offers key opportunities driven by rapid urbanization, industrial expansion, and a global emphasis on sustainable water management. Rising environmental awareness and stringent regulations enhance adoption in regions pressured by water scarcity. Technological integration with AI and IoT for smart management, coupled with demand from sectors like food, pharmaceuticals, and textiles, further boost market potential. Biological Wastewater Treatment Market Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Biological Wastewater Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to Biological Wastewater Treatment Market was valued at USD 10.01 Billion in 2024 and is expected to reach USD 14.34 Billion by 2030, rising at a CAGR of 6.01%. Market growth is being driven by rapid urbanization, expanding industrial activities, and the global push toward sustainable water management. Biological treatment methods, which utilize microorganisms to degrade organic pollutants, are increasingly favored due to their environmental friendliness, cost-efficiency, and effectiveness in treating both municipal and industrial wastewater. Rising awareness about water pollution and stricter regulations governing effluent discharge are accelerating adoption across regions. Urban growth, especially in emerging economies, is straining existing wastewater systems, creating demand for advanced biological solutions. Meanwhile, industries like food & beverage, pharmaceuticals, chemicals, and textiles are adopting these technologies to meet environmental standards and minimize ecological impact. The combined effect of regulatory pressure, industrial demand, and the global need for clean water positions biological wastewater treatment as a critical solution for sustainable wastewater management. Key Market Drivers: Stringent Environmental Regulations on Effluent Discharge Global environmental policies are increasingly enforcing stricter regulations on the discharge of untreated or inadequately treated wastewater. Countries such as the United States, Canada, Germany, and Japan have implemented stringent standards, where failure to comply can lead to heavy penalties or operational halts. Biological wastewater treatment systems are becoming the preferred solution due to their proven ability to effectively remove biodegradable organic materials and nutrients like nitrogen and phosphorus. These capabilities help industries and municipalities meet regulatory benchmarks efficiently. Regulatory frameworks such as the European Union's Urban Waste Water Treatment Directive require biological treatment for communities exceeding 2,000 population equivalents, prompting broader global adoption. Industrial sectors, including pulp & paper, food & beverage, and textiles, are under increasing pressure to adopt or upgrade biological treatment systems to comply with such mandates and ensure sustainable operations. Key Market Challenges: High Capital and Operational Costs of Advanced Biological Systems Despite their environmental advantages, advanced biological wastewater treatment systems pose significant financial challenges. High initial capital outlays are required for building infrastructure such as aeration tanks and sludge handling units, especially for technologies like Membrane Bioreactors (MBR) and Moving Bed Biofilm Reactors (MBBR). This financial burden is particularly daunting for low-income regions and small-scale operators. Moreover, the ongoing operational expenses - including energy-intensive aeration processes, skilled labor, monitoring systems, and regular maintenance - add to the total cost of ownership. The need for periodic replacement of components like membranes or biofilm media further increases lifecycle costs. These economic constraints hinder widespread adoption, especially where municipal budgets are tight or cost-efficiency takes precedence, often resulting in the continued use of less effective or more environmentally harmful alternatives. Key Market Trends: Integration of AI, IoT, and Automation for Smart Process Management The adoption of digital technologies such as AI, IoT, and automation is transforming biological wastewater treatment into a more intelligent and efficient process. These innovations allow real-time monitoring and autonomous control of critical operations, including aeration, nutrient balance, and sludge management. Smart systems can quickly respond to changes in influent conditions, detect microbial imbalances, and automatically adjust parameters to ensure continuous compliance and optimal performance. AI-driven analytics enable predictive maintenance and help minimize system downtimes. IoT-enabled sensors installed across treatment units provide precise data on parameters like dissolved oxygen, pH, BOD, and ammonia levels. These advancements are being embraced globally, particularly in areas with labor shortages or complex treatment needs. Municipal utilities in Europe and industrial zones in China and India are leading adopters of AI-augmented treatment plants, which enhance reliability, reduce manual intervention, and support long-term sustainability. Key Market Players: Veolia Water Technologies SUEZ Water Technologies & Solutions Ecolab Inc. Xylem Inc. Pentair plc AECOM Aquatech International Evoqua Water Technologies Organica Water Kurita Water Industries Ltd. Key Attributes: Report Attribute Details No. of Pages 185 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $10.01 Billion Forecasted Market Value (USD) by 2030 $14.34 Billion Compound Annual Growth Rate 6.0% Regions Covered Global Report Scope: In this report, the Global Biological Wastewater Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: Biological Wastewater Treatment Market, By Type: Aerobic Anaerobic Biological Wastewater Treatment Market, By End-User Industry: Municipal Industrial Biological Wastewater Treatment Market, By Technology: Suspended Growth Systems Attached Growth Systems Integrated Systems Biological Wastewater Treatment Market, By Application: Effluent Treatment Plants Sewage Treatment Plants Common & Combined Effluent Treatment Plants Biological Wastewater Treatment Market, By Region: North America United States Canada Mexico Europe Germany France United Kingdom Italy Spain South America Brazil Argentina Colombia Asia-Pacific China India Japan South Korea Australia Middle East & Africa Saudi Arabia UAE South Africa For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Biological Wastewater Treatment Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store